Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
TNFRSF4 Mouse anti-Human, Clone: UMAB276, liquid, UltraMAB™

Mouse Monoclonal Antibody
Supplier: OriGene UM870166

Description
OX40 (CD134) is a member of the TNF-receptor superfamily, and has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that OX40 promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation.OX40 is not constitutively expressed on resting naive T cells, unlike CD28. OX40 is a secondary costimulatory molecule, expressed after 24 to 72 hours following activation. OX40L, a ligand of OX40, is also not expressed on resting antigen presenting cells. Expression of OX40 is dependent on full activation of the T cell; without CD28, expression of OX40 is delayed and expressed at lower levels.Specifications
TNFRSF4 | |
Monoclonal | |
0.5-1.0 mg/mL | |
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
P43489 | |
TNFRSF4 | |
Full length human recombit protein of human TNFRSF4 produced in HEK293T cell. | |
30 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
Immunohistochemistry (Paraffin) | |
UMAB276 | |
Unconjugated | |
TNFRSF4 | |
ACT35, CD134, IMD16, OX40, TXGP1L | |
Mouse | |
Affinity Chromatography | |
RUO | |
7293 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction